Procter & Gamble Hygiene and Health Care Limited (PGHH.NS)
INR 14120.0
(-0.86%)
INR 14120.0
(-0.86%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.14 Billion | 8.25 Billion | 5.73 Billion | 8.63 Billion | 4.74 Billion | 4.11 Billion |
| Net Income | 6.75 Billion | 8.39 Billion | 7.9 Billion | 8.69 Billion | 5.93 Billion | 6.07 Billion |
| Depreciation & Amortization | 565 Million | 583.6 Million | 528.8 Million | 476.6 Million | 478.8 Million | 497.8 Million |
| Deferred income taxes | - | -2.22 Billion | -2.48 Billion | -2.46 Billion | -1.28 Billion | -2.34 Billion |
| Stock-based compensation | 85 Million | 84.8 Million | 101.5 Million | 69.5 Million | 52.5 Million | 41.8 Million |
| Change in working capital | -2.45 Billion | 1.65 Billion | -166.3 Million | 2.1 Billion | -178.9 Million | 172.3 Million |
| Other non-cash items | 2.08 Billion | -237 Million | -154.2 Million | -250.4 Million | -266.1 Million | -317.4 Million |
| Investing Cash Flow | -432.7 Million | -99.1 Million | -268.5 Million | 69.4 Million | 747.2 Million | 354.6 Million |
| Investments in PPE | -446.8 Million | -444.4 Million | -498 Million | -316 Million | -510.2 Million | -161 Million |
| Acquisitions | 14.1 Million | 200 Thousand | 700 Thousand | 1.4 Million | 6.8 Million | 133.19 Million |
| Investment purchases | -7 Billion | - | - | - | -28.9 Million | -7.2 Million |
| Sales/Maturities of investments | 7 Billion | - | - | - | 22.1 Million | -125.99 Million |
| Other Investing Activities | 457.4 Million | 345.1 Million | 228.8 Million | 384 Million | 1.25 Billion | 515.6 Million |
| Financing Cash Flow | -8.61 Billion | -4.77 Billion | -5.68 Billion | -11.06 Billion | -1.9 Billion | -3.13 Billion |
| Debt repayment | -9.5 Million | -10.7 Million | -16.3 Million | -15.7 Million | -12.9 Million | - |
| Dividends payments | -8.6 Billion | -4.7 Billion | -5.68 Billion | -11.03 Billion | -1.87 Billion | -3.13 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.9 Million | -52.6 Million | 7.5 Million | -11.9 Million | -15 Million | -6.6 Million |
| Accounts receivables | -255.4 Million | -251.1 Million | -488.6 Million | 253.8 Million | 145.1 Million | -331.5 Million |
| Accounts payables | -230.9 Million | 2.06 Billion | 291.1 Million | 2.35 Billion | -232.5 Million | 1.37 Billion |
| Inventory | -183.7 Million | 52.6 Million | 152.8 Million | -442.5 Million | -16.3 Million | -798.1 Million |
| Other working capital | -1.78 Billion | -215.8 Million | -121.6 Million | -64.6 Million | -75.2 Million | -75.5 Million |
| Cash at beginning of period | 9.77 Billion | 6.24 Billion | 6.47 Billion | 8.84 Billion | 5.25 Billion | 3.92 Billion |
| Cash at end of period | 5.88 Billion | 9.63 Billion | 6.24 Billion | 6.47 Billion | 8.84 Billion | 5.25 Billion |
| Capital Expenditure | -446.8 Million | -444.4 Million | -498 Million | -316 Million | -510.2 Million | -161 Million |
| Effect of forex changes on cash | - | 700 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -3.89 Billion | 3.38 Billion | -226.9 Million | -2.36 Billion | 3.58 Billion | 1.33 Billion |
| Free Cash Flow | 4.69 Billion | 7.81 Billion | 5.23 Billion | 8.31 Billion | 4.23 Billion | 3.95 Billion |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 810.6 Million | 6.75 Billion | 1.54 Billion | 2.28 Billion | 2.1 Billion | 8.39 Billion |
| Depreciation & Amortization | - | 565 Million | - | 142.6 Million | 143 Million | 583.6 Million |
| Deferred income taxes | - | - | - | - | - | -2.22 Billion |
| Stock-based compensation | - | 85 Million | - | - | - | 84.8 Million |
| Change in working capital | - | -2.45 Billion | - | - | - | 1.65 Billion |
| Other non-cash items | -810.6 Million | 2.08 Billion | -1.54 Billion | -2.28 Billion | -2.1 Billion | -237 Million |
| Investing Cash Flow | - | -432.7 Million | - | - | - | -99.1 Million |
| Investments in PPE | - | -446.8 Million | - | - | - | -444.4 Million |
| Acquisitions | - | 14.1 Million | - | - | - | 200 Thousand |
| Investment purchases | - | -7 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 7 Billion | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 345.1 Million |
| Financing Cash Flow | - | -8.61 Billion | - | - | - | -4.77 Billion |
| Debt repayment | - | - | - | - | - | -10.7 Million |
| Dividends payments | - | -8.6 Billion | - | - | - | -4.7 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -52.6 Million |
| Accounts receivables | - | -255.4 Million | - | - | - | -251.1 Million |
| Accounts payables | - | -230.9 Million | - | - | - | 2.06 Billion |
| Inventory | - | -183.7 Million | - | - | - | 52.6 Million |
| Other working capital | - | -1.78 Billion | - | - | - | -215.8 Million |
| Cash at beginning of period | - | 9.77 Billion | - | 6.73 Billion | 9.77 Billion | 6.24 Billion |
| Cash at end of period | - | 5.88 Billion | - | 7.02 Billion | 10.06 Billion | 9.63 Billion |
| Capital Expenditure | - | -446.8 Million | - | - | - | -444.4 Million |
| Effect of forex changes on cash | - | - | - | - | - | 700 Thousand |
| Net cash flow / Change in cash | - | -3.89 Billion | - | 285.2 Million | 286 Million | 3.38 Billion |
| Free Cash Flow | - | 4.69 Billion | - | 285.2 Million | 286 Million | 7.81 Billion |
GSTMF
ASTL
CLE
TREIF
JOG
SHRS